Advertisement

We need your help now

Support from readers like you keeps The Journal open.

You are visiting us because we have something you value. Independent, unbiased news that tells the truth. Advertising revenue goes some way to support our mission, but this year it has not been enough.

If you've seen value in our reporting, please contribute what you can, so we can continue to produce accurate and meaningful journalism. For everyone who needs it.

This startup wants everyone to use 'smart' drugs

Would you chew instead of drinking your coffee in the morning?

go_cubes_single_pack-6f55fac3fb825ec4f744c2bbcb24b771 nootrobox.com nootrobox.com

NOOTROBOX WANTS TO change the sketchy reputation associated with brain-boosting supplements.

The startup, founded by 20-somethings Michael Brandt and Geoffrey Woo, makes a variety of nootropics — cognitive performance supplements often casually referred to as “smart” or “brain” drugs — that purport to increase your memory, focus, and energy better than drinking coffee (and without the jitters).

“All these biohackers have been buying random powders off the internet for a while,” Brandt told Business Insider.

People are already doing that, we just want to make it much more accessible.

People on Wall Street and in startup-land alike have been experimenting with ways to make their minds clearer and productivity higher through supplements, and Nootrobox combines their research with proprietary testing to make four supplements: Rise, Sprint, Yawn, and a new gummy coffee-replacement called Go Cubes.

nootrobox Nootrobox Nootrobox

Each one seeks to match a different desired effect and contains a combination of different supplements the FDA classifies as GRAS, or “generally recognised as safe,” like caffeine, vitamins, L-Theanine, an amino acid found in green tea, and bacopa monnieri, a herb known to reduce anxiety and improve memory.

With simple, clean packaging and monthly subscription options, Nootrobox has already been profitable for a while, Brandt says.

The company’s mission of making brain nutrients for the masses piqued the interest of some Silicon Valley bigwigs like Yahoo CEO Marissa Mayer and Zynga CEO Mark Pincus, among others, who invested $500,000 (€441,700) in an angel round of funding for Nootroboox.

sprint_01-b10acc79335bc09bd04d08f59dc8ee77 Nootrobox Nootrobox

With the fresh cash, Brandt and Woo plan to hire more full-timers (versus contract work, like they currently use) to expand the product line and move towards the broader goal of not just selling pills and candies, but also giving customers a way to track health and wellness data and eventually personalize their Nootrobox supplements.

The company wants to be the “welcome mat” for people who haven’t tried nootropics, but eventually help people get as deep into “upgrading their brains” as possible.

“I think we’ll be able to look back and refer to this as the era of ‘dumb supplements,’” Brandt says.

In the future, what you take and when should be different than what I take, based on who you are, based on what you respond to and how.

Brandt and Woo attracted the attention of techie star-power like Mayer, Pincus, LendingHome CEO Matt Humphrey, and Foundation Capital partner Steve Vassallo, through a combination of networking, career history, and dumb luck.

Brandt met Mayer in 2011 when she personally hired him as part of Google’s elite Associate Product Manager program and Pincus happens to work next door.

- Jillian D’Onfro

Read: Bacon, sausages and ham do cause cancer – UN agency>

Readers like you are keeping these stories free for everyone...
A mix of advertising and supporting contributions helps keep paywalls away from valuable information like this article. Over 5,000 readers like you have already stepped up and support us with a monthly payment or a once-off donation.

Published with permission from
View 21 comments
Close
21 Comments
    Submit a report
    Please help us understand how this comment violates our community guidelines.
    Thank you for the feedback
    Your feedback has been sent to our team for review.
    JournalTv
    News in 60 seconds